BRIEF-Merck CEO says would be interested in buying animal health brands at right price

Tue May 6, 2014 12:56pm EDT

May 6 (Reuters) - Merck & Co Inc : * CEO says would be interested in buying animal health brands if they are

"right products at the right price" * Research chief says benefits of experimental odanacatib osteoporosis drug

outweigh potential risks * Says mk-3475 melanoma drug has potential against 30 tumor types * Says global cancer sales now $76 billion, could grow to $120 billon by 2020 * Says still committed to anacetrapib drug to raise "good" hdl cholesterol, and

to bace inhibitor drug for alzheimer's disease * CEO says company's animal health business has global scale, unlike its

consumer healthcare business being sold to Bayer

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.